Price
Frequently asked questions
What is Dexcom's market capitalization?
What is Dexcom's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Dexcom?
What are the analyst ratings and target price for Dexcom's stock?
What is Dexcom's revenue over the trailing twelve months?
What is the EBITDA for Dexcom?
What is the free cash flow of Dexcom?
What is the 5-year beta of Dexcom's stock?
How many employees does Dexcom have, and what sector and industry does it belong to?
What is the free float of Dexcom's shares?
Financials
Market Cap
$28.45B5Y beta
1.11EPS (TTM)
$1.638Free Float
389.35MP/E ratio (TTM)
44.46Revenue (TTM)
$3.95BEBITDA (TTM)
$857.70MFree Cashflow (TTM)
$535.00MPricing
Analyst Ratings
The price target is $152.65 and the stock is covered by 24 analysts.
Buy
20
Hold
4
Sell
0
Information
DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.
9,600
Medical Equipment & Supplies
Health Care
Identifier
ISIN
Primary Ticker